Nu Skin Enterprises (NYSE:NUS) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued on Wednesday.

A number of other equities research analysts also recently issued reports on NUS. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Thursday, December 20th. Pivotal Research reaffirmed a “buy” rating and set a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, March 13th. Tigress Financial reaffirmed a “buy” rating on shares of Nu Skin Enterprises in a research note on Wednesday, November 21st. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Thursday, February 14th. Finally, Citigroup set a $86.00 price target on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research note on Friday, February 15th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $80.25.

Nu Skin Enterprises stock traded down $4.24 during mid-day trading on Wednesday, reaching $52.59. 1,104,100 shares of the company’s stock traded hands, compared to its average volume of 632,089. The company has a market cap of $3.15 billion, a price-to-earnings ratio of 14.94, a PEG ratio of 1.33 and a beta of 0.68. The company has a quick ratio of 1.15, a current ratio of 1.82 and a debt-to-equity ratio of 0.46. Nu Skin Enterprises has a 12-month low of $52.57 and a 12-month high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.05. The company had revenue of $683.29 million for the quarter, compared to the consensus estimate of $676.76 million. Nu Skin Enterprises had a net margin of 4.55% and a return on equity of 25.98%. Nu Skin Enterprises’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.20 earnings per share. On average, equities research analysts anticipate that Nu Skin Enterprises will post 3.91 earnings per share for the current fiscal year.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 1,250 shares of the business’s stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $60.60, for a total transaction of $75,750.00. Following the transaction, the general counsel now owns 32,621 shares in the company, valued at $1,976,832.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 3.00% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the business. Retirement Systems of Alabama increased its position in Nu Skin Enterprises by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 72,023 shares of the company’s stock valued at $4,417,000 after acquiring an additional 260 shares during the last quarter. Commerzbank Aktiengesellschaft FI increased its position in Nu Skin Enterprises by 0.5% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 55,576 shares of the company’s stock valued at $3,408,000 after acquiring an additional 276 shares during the last quarter. United Services Automobile Association increased its position in Nu Skin Enterprises by 2.0% during the fourth quarter. United Services Automobile Association now owns 14,448 shares of the company’s stock valued at $886,000 after acquiring an additional 277 shares during the last quarter. American International Group Inc. increased its position in Nu Skin Enterprises by 0.3% during the fourth quarter. American International Group Inc. now owns 113,316 shares of the company’s stock valued at $6,950,000 after acquiring an additional 344 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its position in Nu Skin Enterprises by 16.0% during the fourth quarter. Advisors Asset Management Inc. now owns 2,720 shares of the company’s stock valued at $167,000 after acquiring an additional 375 shares during the last quarter. Institutional investors and hedge funds own 74.50% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Recommended Story: Straddles

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.